Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases

• Muut tekijät: Wang, Jinghua (Toimittaja)
• Aineistotyyppi: Elektroninen Kirjan osa
• Kieli: englanti
• Julkaistu: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Aiheet: Medicine; PBC; autoantibodies; glycoprotein gp210; nucleoporin p62; KLHL12 peptide; hepatitis B virus; hepatitis B X open reading frame; HBX 3' end region; insertions; deletions; quasispecies; next-generation sequencing; cholestatic diseases; gene therapy; AAV; PFIC; RUNX1; NAFLD; NASH; metabolism; systems biology; ursodeoxycholic acid (UDCA); obeticholic acid (OCA); fibrates; FXR agonists; PPAR agonists; budesonide; transarterial chemoembolization; radiofrequency ablation; hepatocellular carcinoma; type 2 diabetes mellitus; non-alcoholic fatty liver disease; transient hepatic elastography; hepatic steatosis; liver fibrosis; primary biliary cholangitis; obeticholic acid; ursodeoxycholic acid; farnesoid X receptor; HCV; DAA; mitochondria; genotoxicity; side effect; chronic hepatitis B; nucleos(t)ide analogs; miR-125b; biomarker; fibrosis score; fatty liver; cirrhosis; females; gender; liver; n/a
• Linkit: DOAB: download the publication; DOAB: description of the publication

The Special Issue of Biomedicines, entitled "Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases," presents cutting-edge research findings, innovations, and insights into a wide range of topics related to the hepatobiliary system, such as the molecular mechanisms underlying...